Orlando, FL (PRWEB) August 29, 2012
The patient advocates at the Pradaxa Resource Center are alerting those prescribed the blood thinner Pradaxa that experts have linked the drug to severe internal bleeding. Further, a federal judge recently ruled that lawsuits filed by those injured may proceed.
Anyone who has suffered internal bleeding or had a loved one affected by taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.
Pradaxa is a popular anticoagulant drug prescribed to stop strokes and blood clots in patients with atrial fibrillation. According to the Berlin Ad Hoc News on August 27, 2012, manufacturer Boehringer Ingelheim has announced that Pradaxa has now reached one million patient-years of combined prescription time, with use in more than 70 countries worldwide.
On December 7, 2011, however, the FDA warned that it would launch an investigation into Pradaxa after receiving more injury or death reports than expected. According to a USA Today article on August 19, 2012, the agency received 3,781 reports of side effects and 542 deaths among Pradaxa users last year.
Due to the number of Pradaxa lawsuits expected, a central court was recently established in Illinois to handle the claims. The case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. On July 25th, Judge David Herndon issued an order denying attempts by Boehringer Ingelheim to dismiss Pradaxa bleeding lawsuits.
Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options. Due to the specialized nature of these federal MDL cases, the Pradaxa Resource center only recommends lawyers who are already handling Pradaxa lawsuits.